Biallelic Mutations in LRRC56, Encoding a Protein Associated with Intraflagellar Transport, Cause Mucociliary

Serge Bonnefoy1, Christopher M Watson2, Kristin D Kernohan3

  • 1Trypanosome Cell Biology Unit & INSERM U1201, Institut Pasteur, 25, rue du Docteur Roux, 75015 Paris, France.

Insights

Biallelic variants in LRRC56 cause human disease, leading to laterality defects and chronic lung infections due to impaired cilia motility. This protein is crucial for dynein arm assembly during cilia development.

Area of Science:

  • Cell Biology
  • Genetics
  • Human Disease

Background:

  • Primary ciliary defects cause fluid flow dysfunction, leading to respiratory infections, infertility, and laterality defects.
  • Motile cilia are essential for mucus clearance and embryonic development.

Purpose of the Study:

  • Identify genetic variants causing human ciliary dysfunction.
  • Investigate the function of LRRC56 in cilia assembly and motility.

Main Methods:

  • Whole-exome sequencing in affected families.
  • High-speed video microscopy of patient-derived cells.
  • Protein interaction studies and functional analysis in Trypanosoma brucei.

Main Results:

  • Identified biallelic LRRC56 variants in three families with laterality defects and chronic pulmonary infections.
  • LRRC56 interacts with intraflagellar transport protein IFT88.
  • LRRC56 is required for distal outer dynein arm assembly in Trypanosoma brucei, impacting ciliary beat patterns.

Conclusions:

  • Deleterious LRRC56 variants cause a human disease characterized by ciliary dysfunction.
  • LRRC56 plays a conserved role in dynein arm transport during cilia assembly, essential for motility.

Related Concept Videos

Mutations01:39

Mutations

Overview
94.5K
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
309
Protein Transport to the Thylakoids01:22

Protein Transport to the Thylakoids

Thylakoids are membrane-bound sac-like structures within the chloroplast that serve as sites for photosynthesis. Thylakoid lumen contains many electron transport proteins and is enclosed by a thylakoid membrane rich in the light-harvesting complex. Proteins targeted to the thylakoids are transported as precursors and are sorted by the general TOC/TIC import pathway. Once the precursor reaches the stroma, stromal processing peptidases remove their transit signal and expose thylakoid signal...
3.0K
Protein Transport to the Stroma01:24

Protein Transport to the Stroma

Chloroplasts are triple membrane structures with an outer membrane, an inner membrane, and a thylakoid membrane, each containing distinct metabolite transporters, membrane translocons, and enzymes. Appropriate sorting and translocating these proteins to their correct membrane systems is essential for chloroplast function.
Protein complexes called the translocon of the outer chloroplast membrane or TOC complex, and the translocon of the inner chloroplast membrane or TIC complex mediate the...
2.2K
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
553
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
299